(Q83995184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

No association between a functional NAD(P)H: quinone oxidoreductase gene polymorphism (Pro187Ser) and tardive dyskinesia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Hiroko Hori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Takahiro Shinkai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Chima Matsumoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Osamu Ohmori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jun Nakamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

published in

NeuroMolecular Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

375-380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775388%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1385/nmm:8:3:375

30 January 2020

exact match

0 references

cites work

Familial tardive dyskinesia

1 reference

12 December 2020

Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.

1 reference

12 December 2020

Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia

1 reference

12 December 2020

NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity

1 reference

12 December 2020

The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.

1 reference

12 December 2020

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

12 December 2020

Vitamin E in extrapyramidal disorders

1 reference

12 December 2020

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.

1 reference

12 December 2020

Monte Carlo tests for associations between disease and alleles at highly polymorphic loci

1 reference

12 December 2020

Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan

1 reference

12 December 2020

NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia

1 reference

12 December 2020

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

1 reference

12 December 2020

Haploview: analysis and visualization of LD and haplotype maps

1 reference

12 December 2020

Vitamin E treatment of tardive dyskinesia

1 reference

12 December 2020

Drug treatment of Parkinson's disease. Time for phase II

1 reference

12 December 2020

Expected incidence of tardive dyskinesia associated with atypical antipsychotics.

1 reference

12 December 2020

Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride

1 reference

12 December 2020

Research Diagnoses for Tardive Dyskinesia

1 reference

12 December 2020

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

1 reference

12 December 2020

Pharmacological options for the management of dyskinesias

1 reference

12 December 2020

The International HapMap Project

1 reference

12 December 2020

Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation

1 reference

12 December 2020

Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia

1 reference

12 December 2020